Difference between revisions of "Part:BBa K2913006"
(4 intermediate revisions by 3 users not shown) | |||
Line 3: | Line 3: | ||
<partinfo>BBa_K2913006 short</partinfo> | <partinfo>BBa_K2913006 short</partinfo> | ||
− | This composite part consists of Plac BBa_K2913004 , conjugation sequence BBa_K2913002, and HucO | + | This composite part consists of Plac-conjugation [https://parts.igem.org/Part:BBa_K2913004 BBa_K2913004] , conjugation sequence [https://parts.igem.org/Part:BBa_K2913002 BBa_K2913002], and HucO sequence[https://parts.igem.org/Part:BBa_K2913001 BBa_K2913001], which is the only one hucR binding site of Phuc2[https://parts.igem.org/Part:BBa_K2913005 BBa_K2913005]. In the absence of uric acid (or xanthine), HucR protein binds to HucO and prevents the binding of RNA polymerase. When uric acid (or xanthine) antagonizes the HucR-HucO binding, RNA polymerase initiates a transcriptional process of downstream genes. |
+ | |||
+ | <b>The series of Phuc</b> : | ||
+ | |||
+ | [https://parts.igem.org/Part:BBa_K2913005 Phuc1] | ||
+ | |||
+ | [https://parts.igem.org/Part:BBa_K2913006 Phuc2] | ||
+ | |||
+ | [https://parts.igem.org/Part:BBa_K2913007 Phuc3] | ||
− | |||
===Usage and Biology=== | ===Usage and Biology=== | ||
=result= | =result= | ||
− | The promoter should be fully activated at the highest uric acid concentration safe to human body (0.465mM). The activity of the promoters were determined by measuring the fluorescence intensity of the enhanced green fluorescent protein (EGFP). The results showed that the Phuc2 had the highest sensitive and activity at the conditions of 0.1mM and 0.01 mM of uric acid. Then, the EGFP coding sequence was replaced by the uricase gene to check whether the module could sense and metabolize the uric acid. As shown in Fig.5, the control group kept constant uric acid levels, but the experimental group displayed reduced uric acid concentrations in a time-dependent manner in the first 3 h of incubation. After that, the uric acid levels kept constant. The data suggested that the expression of uricase was induced at high concentrations of uric acid and repressed at its relatively low concentrations. The result indicated that the expression of uricase was under the control of Phuc2 responsive to the concentration of uric acid. | + | The promoter should be fully activated at the highest uric acid concentration safe to human body (0.465mM). The activity of the promoters were determined by measuring the fluorescence intensity of the enhanced green fluorescent protein (EGFP). The results showed that the Phuc2 had the highest sensitive and activity at the conditions of 0.1mM and 0.01 mM of uric acid. Then, the EGFP coding sequence was replaced by the uricase gene to check whether the module could sense and metabolize the uric acid. As shown in Fig.5, the control group kept constant uric acid levels, but the experimental group displayed reduced uric acid concentrations in a time-dependent manner in the first 3 h of incubation. After that, the uric acid levels kept constant. The data suggested that the expression of uricase was induced at high concentrations of uric acid and repressed at its relatively low concentrations. The result indicated that the expression of uricase was under the control of Phuc2 responsive to the concentration of uric acid.<b>[https://2019.igem.org/Team:NEFU_China/Results See more information on iGEM19_NEFU_China's Result PAGE]</b> |
[[File:T--NEFU_China--parts--hucr3.png|500px|thumb|left|Fig. 3 Comparison of induction strength of the promoter Phuc1 (circle), Phuc2 (square), and Phuc3 (triangle) by measuring green fluorescence of EGFP at 0.1 mM of the inducer uric acid (with 1:100 dilution of culture inoculation). Error bars represent standard deviations.]] | [[File:T--NEFU_China--parts--hucr3.png|500px|thumb|left|Fig. 3 Comparison of induction strength of the promoter Phuc1 (circle), Phuc2 (square), and Phuc3 (triangle) by measuring green fluorescence of EGFP at 0.1 mM of the inducer uric acid (with 1:100 dilution of culture inoculation). Error bars represent standard deviations.]] |
Latest revision as of 21:27, 21 October 2019
Phuc2, one of the series of Phuc
This composite part consists of Plac-conjugation BBa_K2913004 , conjugation sequence BBa_K2913002, and HucO sequenceBBa_K2913001, which is the only one hucR binding site of Phuc2BBa_K2913005. In the absence of uric acid (or xanthine), HucR protein binds to HucO and prevents the binding of RNA polymerase. When uric acid (or xanthine) antagonizes the HucR-HucO binding, RNA polymerase initiates a transcriptional process of downstream genes.
The series of Phuc :
Usage and Biology
result
The promoter should be fully activated at the highest uric acid concentration safe to human body (0.465mM). The activity of the promoters were determined by measuring the fluorescence intensity of the enhanced green fluorescent protein (EGFP). The results showed that the Phuc2 had the highest sensitive and activity at the conditions of 0.1mM and 0.01 mM of uric acid. Then, the EGFP coding sequence was replaced by the uricase gene to check whether the module could sense and metabolize the uric acid. As shown in Fig.5, the control group kept constant uric acid levels, but the experimental group displayed reduced uric acid concentrations in a time-dependent manner in the first 3 h of incubation. After that, the uric acid levels kept constant. The data suggested that the expression of uricase was induced at high concentrations of uric acid and repressed at its relatively low concentrations. The result indicated that the expression of uricase was under the control of Phuc2 responsive to the concentration of uric acid.See more information on iGEM19_NEFU_China's Result PAGE
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]